Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 Financi... ( NEW YORK Aug. 4 2011 /- Keryx Biophar...)

Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 Financial Results

Date:8/4/2011

NEW YORK, Aug. 4, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease, today announced that a conference call will be held on Monday, August 8, 2011 at 8:30 a.m. EDT to discuss results for the second quarter ended June 30, 2011 and a business outlook for the remainder of 2011. Ron Bentsur, Chief Executive Officer of Keryx, will host the call.

In order to participate in the conference call, please call 1-877-869-3847 (U.S.), 1-201-689-8261 (outside the U.S.), call-in ID: KERYX. The audio recording of the conference call will be available for replay at http://www.keryx.com, for a period of 15 days after the call.

Keryx will announce its financial results for this period in a press release to be issued prior to the call.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, and also affects a number of other key signal transduction pathways, including the JNK pathway, all of which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 3 clinical development for both refractory advanced colorectal cancer and multiple myeloma, and in Phase 1 and 2 clinical development for several other tumor types. Each of the KRX-0401 Phase 3 studies is being conducted under a Special Protocol Assessment (SPA) agree
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:5/24/2013)... LOVELAND, Colo. , May 24, 2013 Heska Corporation ... veterinary diagnostic and specialty products, announced today that Dr. ... executive officer, and Jason Napolitano , executive ... Second Annual Marcum MicroCap Conference, which is being held May ... at the Grand Hyatt Hotel. The Company,s ...

(Date:5/24/2013)... 24, 2013 In accordance with Rule 17.1 and ... of the United States Exchange Act, Echo Pharma Acquisition Limited ... Elan Corporation (NYSE: ELN). Background On ... an offer for the entire of the issued and to ... "Original Offer"). On 20 May 2013, Royalty ...

(Date:5/24/2013)... England and BOSTON , May ... drug discovery and development company, is pleased to announce that it ... Consultant to augment the Company,s business development capabilities in ... has more than 15 years of experience in business development, licensing ... Perlegen Sciences, Inc., Roche Pharma ( Japan ), Nippon ...

[0] Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference [0] Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements [0] Heptares Augments Business Development Capabilities in Japan and Other Asian Territories

... WORCESTER, Mass., Jan. 6, 2011 Generex Biotechnology ... GNBT ), together with its wholly-owned immunotherapeutic ... and RXi Pharmaceuticals Corporation ( www.rxipharma.com ) (NasdaqCM: ... announced that they have obtained positive early research ...

... Nutrastar International Inc. (OTC Bulletin Board: NUIN ... supplier of premium branded Traditional Chinese Medicine ("TCM") consumer ... in the upcoming Cowen and Company 9th Annual Consumer ... Times Square (270 West 43rd Street) in New York ...

Cached Medicine Technology:Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology in the Development of Therapeutic Vaccines for Cancer 2 Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology in the Development of Therapeutic Vaccines for Cancer 3 Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology in the Development of Therapeutic Vaccines for Cancer 4 Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology in the Development of Therapeutic Vaccines for Cancer 5 Nutrastar to Present at the Cowen and Company 9th Annual Consumer Conference in NYC 2 Nutrastar to Present at the Cowen and Company 9th Annual Consumer Conference in NYC 3

Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology in the Development of Therapeutic Vaccines for Cancer Nutrastar to Present at the Cowen and Company 9th Annual Consumer Conference in NYC

(Date:5/25/2013)... An experienced Chandler dentist has just launched a ... Surge, LLC. , http://www.ChandlerDentalExcellence.com/Teeth-Whitening.php , Several ... the treatment, can be performed in the office or ... will be chosen for the individual patient. , In-office ... peroxide-based whitening gel is used along with a whitening ...

(Date:5/25/2013)... News) -- Many viruses and parasites that affect both ... a bacteria-borne illness than can result in liver or ... according to a veterinarian. These germs could ... air, said Dr. Susan Nelson, a clinical associate professor ... these serious diseases can be fatal, even with treatment," ...

(Date:5/25/2013)... May 25, 2013 Providing patients with their ... Doc team of weight management professionals. But, aside from educating ... effectively, Diet Doc’s hCG diets also provide patients, ... during childhood like bullying, more control over their lives by ... dealing with the underlying factors of weight gain derived from ...

(Date:5/25/2013)... New York,NY (PRWEB) May 25, 2013 ... SizeItUp officially declared the integration of the 2012 ... Lamborghini Aventador is the latest entrant in the list ... Designed intelligently, the vehicle is all set to thrill ... with vicious acceleration power and spectacular looks, the 2012 ...

(Date:5/25/2013)... According to world-renowned scholars, Queen Cleopatra VII ... that ever lived. Cleopatra’s legendary beauty moved nations and ... powerful men in her time. Cleopatra was also a ... skin glowing and fresh, from her legendary milk baths ... and cyprus grass. , Cleopatra was said to possess ...

Breaking Medicine News(10 mins):Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2 Health News:Hidden Dangers Dog Dog Parks 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3 Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3

[0] Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC [0] Hidden Dangers Dog Dog Parks [0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain [0] Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador [0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician

... grant from the Agency for Healthcare Research and Quality ... the comparative effectiveness of positron emission tomography (PET) and ... on the diagnosis and management of cancer patients, but ... , "Comparative effectiveness research is essential to the future ...

... Intacs ... provided by Khanna institute in Beverly Hills , ... (Vocus) April 13, 2010 -- Khanna Institute, which expanded into Beverly Hills, ... that it is offering its Beverly Hills patients the opportunity to obtain a product known ...

... ... Videoconferencing System at the National Association of Broadcasters (NAB) show in Las ... lower price point than existing systems. Espresso HD uses patented next-generation ... ultra-fast set up and installation, better visual performance than competitive solutions using ...

... most of the brain tumor can often be removed surgically, ... this is that sporadic, infiltrative tumor cells will remain in ... University of Bonn have now subjected these ,forgotten, cells to ... were able to show that many of the fundamental properties ...

... , PHILADELPHIA Molecular biologist Jonathan Brody, Ph.D., assistant ... Thomas Jefferson University, has been awarded a 2010 Pancreatic ... (AACR) Career Development Award in memory of Skip Viragh. ... to help support his innovative research in pancreatic cancer. ...

... ... 80% of Women Enjoy Reading or Viewing Pornography; 73% Wish They Were Having More Sex. ... San Francisco, CA (PRWEB) April 13, 2010 ... a copy of What Women Really Want in Bed: The Surprising Secrets Women Wish Men ...

Cached Medicine News:Health News:SNM receives grant from AHRQ for comparative effectiveness research 2 Health News:Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills 2 Health News:Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills 3 Health News:HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions 2 Health News:HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions 3 Health News:HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions 4 Health News:Brain cancer: Study focuses on forgotten cells 2 Health News:Jefferson researcher receives 2010 Pancreatic Cancer Action Network-AACR Career Development Award 2 Health News:'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants 2 Health News:'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants 3 Health News:'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants 4

SNM receives grant from AHRQ for comparative effectiveness research Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions Brain cancer: Study focuses on forgotten cells Jefferson researcher receives 2010 Pancreatic Cancer Action Network-AACR Career Development Award 'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants

... Single Use Loading Units With Titanium ... Use Reloadable Staplers With Titanium Staples)., ... 80 single use surgical staplers with MULTIFIRE ... units and the Auto Suture™ MULTIFIRE SGIA™ ...

... Staplers are anastomotic staplers available in four ... to lumen diameter. The staplers permit tissue ... improve access and ease of use. The ... compression by adjusting the height of the ...

... for use with VALTRAC™ Devices ... ,The Purstring™ Device is ... esophageal surgery for the placement ... is intended for use with ...

The Auto Suture™ EEA™ 34mm reusable stainless steel sizer has application in intestinal, colorectal and esophageal surgery to help evaluate the diameter of tubular structures....

Medicine Products:

MULTIFIRE GIA™ (Single Use Loading Units With Titanium Staples)PROXIMATE ILS Curved Intraluminal Staplers VALTRAC™ Sizer Device EEA™ Reusable 34 mm Sizer